Verescence, global leader in glass packaging for the Perfumery and Cosmetics industries, is announcing the arrival of Stirling Square Capital Partners, a leading pan-European private equity firm, as new shareholder of the group.
For over 120 years, Verescence is a privileged partner of the biggest brands due to its extensive know-how and expertise. Verescence produces 500 million bottles per year in its 3 glass production sites and its 4 decoration sites in Europe and North America. In 2018, the company employed 2,300 people worldwide and achieved sales revenue of 305 million euros.
« The arrival of Stirling Square Capital Partners as new shareholder of our group, will enable us to accelerate our international expansion and our new strategic plan Verescence 2022 - Forming the future. A project which includes a massive investment plan of 122 million euros. », comments Thomas Riou, President of Verescence.
« Verescence is the genuine best-in-class player in its field, acting as a critical supplier to the world’s most prestigious brands. It is a true innovator in its category, expanding the design and technical boundaries of what can be achieved. We are delighted to partner with CEO Thomas Riou and his highly accomplished team to continue the Company’s journey towards operational excellence. », said Julien Horreard, Partner at Stirling Square Capital Partners.
12.03.2019, Verescence
此网站新闻材料的版权属于公司或第三方的新闻提供者，其所有权利保留。所有新闻材料对其访问者只能限于其本人使用，并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供，当应用此新闻材料时，每个使用者都同意遵守，并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.